Works matching IS 19466234 AND DT 2016 AND VI 8 AND IP 360

Results: 4
    1
    2

    Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases.

    Published in:
    Science Translational Medicine, 2016, v. 8, n. 360, p. 1, doi. 10.1126/scitranslmed.aaf5219
    By:
    • Rahbari, Nuh N.;
    • Kedrin, Dmitriy;
    • Incio, Joao;
    • Hao Liu;
    • Ho, William W.;
    • Nia, Hadi T.;
    • Edrich, Christina M.;
    • Keehoon Jung;
    • Daubriac, Julien;
    • Ivy Chen;
    • Takahiro Heishi;
    • Martin, John D.;
    • Yuhui Huang;
    • Maimon, Nir;
    • Reissfelder, Christoph;
    • Weitz, Jurgen;
    • Boucher, Yves;
    • Clark, Jeffrey W.;
    • Grodzinsky, Alan J.;
    • Duda, Dan G.
    Publication type:
    Article
    3
    4

    First-in-class inhibitor of the T cell receptor for the treatment of autoimmune diseases.

    Published in:
    Science Translational Medicine, 2016, v. 8, n. 360, p. 1, doi. 10.1126/scitranslmed.aaf2140
    By:
    • Borroto, Aldo;
    • Reyes-Garau, Diana;
    • Jiménez, M. Angeles;
    • Carrasco, Esther;
    • Moreno, Beatriz;
    • Martínez-Pasamar, Sara;
    • Cortés, José R.;
    • Perona, Almudena;
    • Abia, David;
    • Blanco, Soledad;
    • Fuentes, Manuel;
    • Arellano, Irene;
    • Lobo, Juan;
    • Heidarieh, Haleh;
    • Rueda, Javier;
    • Esteve, Pilar;
    • Cibrián, Danay;
    • Martinez-Riaño, Ana;
    • Mendoza, Pilar;
    • Prieto, Cristina
    Publication type:
    Article